nodes	percent_of_prediction	percent_of_DWPC	metapath
Methyldopa—SLC15A1—Ramipril—type 1 diabetes mellitus	0.812	1	CbGbCtD
Methyldopa—Antinuclear antibody positive—Ramipril—type 1 diabetes mellitus	0.0124	0.14	CcSEcCtD
Methyldopa—DDC—nerve—type 1 diabetes mellitus	0.00707	0.235	CbGeAlD
Methyldopa—DDC—Biogenic Amine Synthesis—GAD2—type 1 diabetes mellitus	0.00563	0.0914	CbGpPWpGaD
Methyldopa—COMT—Biogenic Amine Synthesis—GAD2—type 1 diabetes mellitus	0.005	0.0812	CbGpPWpGaD
Methyldopa—DDC—Biogenic Amine Synthesis—GAD1—type 1 diabetes mellitus	0.00488	0.0793	CbGpPWpGaD
Methyldopa—COMT—Biogenic Amine Synthesis—GAD1—type 1 diabetes mellitus	0.00433	0.0704	CbGpPWpGaD
Methyldopa—Bone marrow depression—Ramipril—type 1 diabetes mellitus	0.00418	0.0471	CcSEcCtD
Methyldopa—DDC—Nicotine Activity on Dopaminergic Neurons—SLC18A2—type 1 diabetes mellitus	0.00377	0.0612	CbGpPWpGaD
Methyldopa—Endocrine disorder—Ramipril—type 1 diabetes mellitus	0.00341	0.0383	CcSEcCtD
Methyldopa—Liver injury—Ramipril—type 1 diabetes mellitus	0.00336	0.0378	CcSEcCtD
Methyldopa—ADRA2A—peripheral nervous system—type 1 diabetes mellitus	0.00306	0.102	CbGeAlD
Methyldopa—Vasculitis—Ramipril—type 1 diabetes mellitus	0.00289	0.0325	CcSEcCtD
Methyldopa—DDC—Dopaminergic Neurogenesis—SLC18A2—type 1 diabetes mellitus	0.00283	0.046	CbGpPWpGaD
Methyldopa—Hepatocellular injury—Ramipril—type 1 diabetes mellitus	0.00282	0.0318	CcSEcCtD
Methyldopa—DDC—nephron tubule—type 1 diabetes mellitus	0.00276	0.0918	CbGeAlD
Methyldopa—Lightheadedness—Ramipril—type 1 diabetes mellitus	0.00253	0.0284	CcSEcCtD
Methyldopa—Gynaecomastia—Ramipril—type 1 diabetes mellitus	0.00253	0.0284	CcSEcCtD
Methyldopa—DDC—kidney—type 1 diabetes mellitus	0.00242	0.0807	CbGeAlD
Methyldopa—Haemolytic anaemia—Ramipril—type 1 diabetes mellitus	0.00227	0.0255	CcSEcCtD
Methyldopa—COMT—islet of Langerhans—type 1 diabetes mellitus	0.00227	0.0754	CbGeAlD
Methyldopa—Nasal congestion—Ramipril—type 1 diabetes mellitus	0.00225	0.0253	CcSEcCtD
Methyldopa—Libido decreased—Ramipril—type 1 diabetes mellitus	0.00221	0.0249	CcSEcCtD
Methyldopa—SLC15A1—nephron tubule—type 1 diabetes mellitus	0.00205	0.0683	CbGeAlD
Methyldopa—Disturbance in sexual arousal—Ramipril—type 1 diabetes mellitus	0.00203	0.0229	CcSEcCtD
Methyldopa—Liver function test abnormal—Ramipril—type 1 diabetes mellitus	0.00189	0.0213	CcSEcCtD
Methyldopa—Orthostatic hypotension—Ramipril—type 1 diabetes mellitus	0.00187	0.0211	CcSEcCtD
Methyldopa—ADRA2A—Adrenoceptors—ADRB1—type 1 diabetes mellitus	0.00186	0.0303	CbGpPWpGaD
Methyldopa—Breast disorder—Ramipril—type 1 diabetes mellitus	0.00185	0.0208	CcSEcCtD
Methyldopa—Toxic epidermal necrolysis—Ramipril—type 1 diabetes mellitus	0.00185	0.0208	CcSEcCtD
Methyldopa—COMT—nephron tubule—type 1 diabetes mellitus	0.00182	0.0607	CbGeAlD
Methyldopa—SLC15A1—kidney—type 1 diabetes mellitus	0.0018	0.06	CbGeAlD
Methyldopa—Eosinophilia—Ramipril—type 1 diabetes mellitus	0.00175	0.0197	CcSEcCtD
Methyldopa—Isoetarine—ADRB1—type 1 diabetes mellitus	0.00175	0.236	CrCbGaD
Methyldopa—Pancreatitis—Ramipril—type 1 diabetes mellitus	0.00174	0.0195	CcSEcCtD
Methyldopa—Angina pectoris—Ramipril—type 1 diabetes mellitus	0.00173	0.0194	CcSEcCtD
Methyldopa—Pancytopenia—Ramipril—type 1 diabetes mellitus	0.00168	0.0189	CcSEcCtD
Methyldopa—Norepinephrine—SLC18A2—type 1 diabetes mellitus	0.00166	0.223	CrCbGaD
Methyldopa—COMT—cardiovascular system—type 1 diabetes mellitus	0.00164	0.0545	CbGeAlD
Methyldopa—Erectile dysfunction—Ramipril—type 1 diabetes mellitus	0.00163	0.0184	CcSEcCtD
Methyldopa—Weight increased—Ramipril—type 1 diabetes mellitus	0.00161	0.0181	CcSEcCtD
Methyldopa—COMT—kidney—type 1 diabetes mellitus	0.0016	0.0534	CbGeAlD
Methyldopa—COMT—pancreas—type 1 diabetes mellitus	0.00159	0.053	CbGeAlD
Methyldopa—Jaundice—Ramipril—type 1 diabetes mellitus	0.00154	0.0173	CcSEcCtD
Methyldopa—Hepatobiliary disease—Ramipril—type 1 diabetes mellitus	0.00149	0.0168	CcSEcCtD
Methyldopa—Agranulocytosis—Ramipril—type 1 diabetes mellitus	0.00147	0.0166	CcSEcCtD
Methyldopa—Hepatitis—Ramipril—type 1 diabetes mellitus	0.00142	0.016	CcSEcCtD
Methyldopa—Connective tissue disorder—Ramipril—type 1 diabetes mellitus	0.00139	0.0157	CcSEcCtD
Methyldopa—Mediastinal disorder—Ramipril—type 1 diabetes mellitus	0.00128	0.0144	CcSEcCtD
Methyldopa—Mental disorder—Ramipril—type 1 diabetes mellitus	0.00124	0.014	CcSEcCtD
Methyldopa—ADRA2A—islet of Langerhans—type 1 diabetes mellitus	0.00115	0.0384	CbGeAlD
Methyldopa—Leukopenia—Ramipril—type 1 diabetes mellitus	0.0011	0.0124	CcSEcCtD
Methyldopa—DDC—Tryptophan metabolism—CAT—type 1 diabetes mellitus	0.00109	0.0176	CbGpPWpGaD
Methyldopa—Arthralgia—Ramipril—type 1 diabetes mellitus	0.00105	0.0118	CcSEcCtD
Methyldopa—Myalgia—Ramipril—type 1 diabetes mellitus	0.00105	0.0118	CcSEcCtD
Methyldopa—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 1 diabetes mellitus	0.00104	0.0117	CcSEcCtD
Methyldopa—Oedema—Ramipril—type 1 diabetes mellitus	0.00101	0.0113	CcSEcCtD
Methyldopa—DDC—Circadian rythm related genes—PAX4—type 1 diabetes mellitus	0.00099	0.0161	CbGpPWpGaD
Methyldopa—Nervous system disorder—Ramipril—type 1 diabetes mellitus	0.000988	0.0111	CcSEcCtD
Methyldopa—Thrombocytopenia—Ramipril—type 1 diabetes mellitus	0.000986	0.0111	CcSEcCtD
Methyldopa—Skin disorder—Ramipril—type 1 diabetes mellitus	0.000978	0.011	CcSEcCtD
Methyldopa—Musculoskeletal discomfort—Ramipril—type 1 diabetes mellitus	0.000918	0.0103	CcSEcCtD
Methyldopa—Paraesthesia—Ramipril—type 1 diabetes mellitus	0.000904	0.0102	CcSEcCtD
Methyldopa—SLC15A1—SLC-mediated transmembrane transport—SLC29A3—type 1 diabetes mellitus	0.000903	0.0147	CbGpPWpGaD
Methyldopa—ADRA2A—Monoamine GPCRs—CHRM2—type 1 diabetes mellitus	0.000899	0.0146	CbGpPWpGaD
Methyldopa—Gastrointestinal disorder—Ramipril—type 1 diabetes mellitus	0.00087	0.00979	CcSEcCtD
Methyldopa—Constipation—Ramipril—type 1 diabetes mellitus	0.000861	0.00969	CcSEcCtD
Methyldopa—COMT—Phase II conjugation—GSTT1—type 1 diabetes mellitus	0.000851	0.0138	CbGpPWpGaD
Methyldopa—ADRA2A—pancreas—type 1 diabetes mellitus	0.000811	0.027	CbGeAlD
Methyldopa—Droxidopa—ADRB1—type 1 diabetes mellitus	0.0008	0.108	CrCbGaD
Methyldopa—Body temperature increased—Ramipril—type 1 diabetes mellitus	0.000796	0.00896	CcSEcCtD
Methyldopa—ADRA2A—Amine ligand-binding receptors—CHRM2—type 1 diabetes mellitus	0.000755	0.0123	CbGpPWpGaD
Methyldopa—Hypersensitivity—Ramipril—type 1 diabetes mellitus	0.000742	0.00835	CcSEcCtD
Methyldopa—DDC—SIDS Susceptibility Pathways—CHRM2—type 1 diabetes mellitus	0.000735	0.0119	CbGpPWpGaD
Methyldopa—Isoprenaline—ADRB1—type 1 diabetes mellitus	0.000727	0.0979	CrCbGaD
Methyldopa—Asthenia—Ramipril—type 1 diabetes mellitus	0.000723	0.00813	CcSEcCtD
Methyldopa—Diarrhoea—Ramipril—type 1 diabetes mellitus	0.000689	0.00776	CcSEcCtD
Methyldopa—Norepinephrine—ADRB1—type 1 diabetes mellitus	0.000674	0.0907	CrCbGaD
Methyldopa—DDC—Circadian rythm related genes—PRF1—type 1 diabetes mellitus	0.000669	0.0109	CbGpPWpGaD
Methyldopa—Dizziness—Ramipril—type 1 diabetes mellitus	0.000666	0.0075	CcSEcCtD
Methyldopa—ADRA2A—Monoamine GPCRs—ADRB1—type 1 diabetes mellitus	0.00066	0.0107	CbGpPWpGaD
Methyldopa—Vomiting—Ramipril—type 1 diabetes mellitus	0.00064	0.00721	CcSEcCtD
Methyldopa—Rash—Ramipril—type 1 diabetes mellitus	0.000635	0.00715	CcSEcCtD
Methyldopa—DDC—Dopaminergic Neurogenesis—STAT3—type 1 diabetes mellitus	0.000635	0.0103	CbGpPWpGaD
Methyldopa—Dermatitis—Ramipril—type 1 diabetes mellitus	0.000634	0.00714	CcSEcCtD
Methyldopa—Headache—Ramipril—type 1 diabetes mellitus	0.000631	0.0071	CcSEcCtD
Methyldopa—COMT—Transmission across Chemical Synapses—GAD2—type 1 diabetes mellitus	0.000629	0.0102	CbGpPWpGaD
Methyldopa—Dopamine—ADRB1—type 1 diabetes mellitus	0.000626	0.0843	CrCbGaD
Methyldopa—DDC—Parkinsons Disease Pathway—CASP3—type 1 diabetes mellitus	0.000625	0.0102	CbGpPWpGaD
Methyldopa—ADRA2A—Regulation of insulin secretion—ABCC8—type 1 diabetes mellitus	0.000614	0.00997	CbGpPWpGaD
Methyldopa—Epinephrine—ADRB1—type 1 diabetes mellitus	0.000611	0.0823	CrCbGaD
Methyldopa—Nausea—Ramipril—type 1 diabetes mellitus	0.000598	0.00673	CcSEcCtD
Methyldopa—Epinephrine—TNF—type 1 diabetes mellitus	0.00058	0.0781	CrCbGaD
Methyldopa—ADRA2A—Amine ligand-binding receptors—ADRB1—type 1 diabetes mellitus	0.000554	0.00901	CbGpPWpGaD
Methyldopa—COMT—Neuronal System—ABCC8—type 1 diabetes mellitus	0.000551	0.00896	CbGpPWpGaD
Methyldopa—COMT—Transmission across Chemical Synapses—SLC18A2—type 1 diabetes mellitus	0.000551	0.00895	CbGpPWpGaD
Methyldopa—SLC15A1—SLC-mediated transmembrane transport—G6PC2—type 1 diabetes mellitus	0.000547	0.00889	CbGpPWpGaD
Methyldopa—COMT—Transmission across Chemical Synapses—GAD1—type 1 diabetes mellitus	0.000545	0.00886	CbGpPWpGaD
Methyldopa—DDC—SIDS Susceptibility Pathways—SST—type 1 diabetes mellitus	0.000542	0.0088	CbGpPWpGaD
Methyldopa—COMT—Biological oxidations—GSTT1—type 1 diabetes mellitus	0.000498	0.00809	CbGpPWpGaD
Methyldopa—ADRA2A—Regulation of insulin secretion—KCNJ11—type 1 diabetes mellitus	0.000485	0.00788	CbGpPWpGaD
Methyldopa—ADRA2A—Integration of energy metabolism—ABCC8—type 1 diabetes mellitus	0.000483	0.00784	CbGpPWpGaD
Methyldopa—COMT—Neuronal System—GAD2—type 1 diabetes mellitus	0.000482	0.00783	CbGpPWpGaD
Methyldopa—SLC15A1—Transmembrane transport of small molecules—SLC29A3—type 1 diabetes mellitus	0.000459	0.00745	CbGpPWpGaD
Methyldopa—ADRA2A—G alpha (z) signalling events—PRKCQ—type 1 diabetes mellitus	0.000443	0.0072	CbGpPWpGaD
Methyldopa—COMT—Neuronal System—KCNJ11—type 1 diabetes mellitus	0.000436	0.00708	CbGpPWpGaD
Methyldopa—COMT—Neuronal System—SLC18A2—type 1 diabetes mellitus	0.000422	0.00686	CbGpPWpGaD
Methyldopa—COMT—Neuronal System—GAD1—type 1 diabetes mellitus	0.000418	0.00679	CbGpPWpGaD
Methyldopa—ADRA2A—Regulation of insulin secretion—ITPR3—type 1 diabetes mellitus	0.00041	0.00665	CbGpPWpGaD
Methyldopa—DDC—SIDS Susceptibility Pathways—IL10—type 1 diabetes mellitus	0.000386	0.00627	CbGpPWpGaD
Methyldopa—ADRA2A—Integration of energy metabolism—KCNJ11—type 1 diabetes mellitus	0.000382	0.0062	CbGpPWpGaD
Methyldopa—SLC15A1—SLC-mediated transmembrane transport—SLC18A2—type 1 diabetes mellitus	0.000363	0.0059	CbGpPWpGaD
Methyldopa—SLC15A1—SLC-mediated transmembrane transport—CP—type 1 diabetes mellitus	0.000334	0.00543	CbGpPWpGaD
Methyldopa—SLC15A1—SLC-mediated transmembrane transport—SLC11A1—type 1 diabetes mellitus	0.000331	0.00538	CbGpPWpGaD
Methyldopa—ADRA2A—Integration of energy metabolism—ITPR3—type 1 diabetes mellitus	0.000322	0.00523	CbGpPWpGaD
Methyldopa—ADRA2A—Regulation of insulin secretion—GCG—type 1 diabetes mellitus	0.0003	0.00487	CbGpPWpGaD
Methyldopa—SLC15A1—Transmembrane transport of small molecules—G6PC2—type 1 diabetes mellitus	0.000278	0.00452	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—SIRPG—type 1 diabetes mellitus	0.000259	0.00421	CbGpPWpGaD
Methyldopa—DDC—Circadian rythm related genes—CDK4—type 1 diabetes mellitus	0.000249	0.00404	CbGpPWpGaD
Methyldopa—DDC—Circadian rythm related genes—NOS2—type 1 diabetes mellitus	0.000242	0.00393	CbGpPWpGaD
Methyldopa—SLC15A1—Transmembrane transport of small molecules—ABCC8—type 1 diabetes mellitus	0.000241	0.00392	CbGpPWpGaD
Methyldopa—ADRA2A—Integration of energy metabolism—GCG—type 1 diabetes mellitus	0.000236	0.00383	CbGpPWpGaD
Methyldopa—DDC—SIDS Susceptibility Pathways—IL1B—type 1 diabetes mellitus	0.000202	0.00329	CbGpPWpGaD
Methyldopa—DDC—SIDS Susceptibility Pathways—CASP3—type 1 diabetes mellitus	0.000202	0.00328	CbGpPWpGaD
Methyldopa—ADRA2A—G alpha (i) signalling events—GAL—type 1 diabetes mellitus	0.000201	0.00327	CbGpPWpGaD
Methyldopa—ADRA2A—G alpha (i) signalling events—CCL20—type 1 diabetes mellitus	0.000199	0.00323	CbGpPWpGaD
Methyldopa—DDC—Metabolism—HBA2—type 1 diabetes mellitus	0.000192	0.00312	CbGpPWpGaD
Methyldopa—ADRA2A—G alpha (i) signalling events—CHRM2—type 1 diabetes mellitus	0.000187	0.00304	CbGpPWpGaD
Methyldopa—SLC15A1—Transmembrane transport of small molecules—SLC18A2—type 1 diabetes mellitus	0.000185	0.003	CbGpPWpGaD
Methyldopa—DDC—Metabolism—G6PC2—type 1 diabetes mellitus	0.00018	0.00293	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet activation, signaling and aggregation—ITPR3—type 1 diabetes mellitus	0.000176	0.00286	CbGpPWpGaD
Methyldopa—ADRA2A—GPCRs, Class A Rhodopsin-like—CHRM2—type 1 diabetes mellitus	0.000173	0.00282	CbGpPWpGaD
Methyldopa—COMT—Metabolism—HBA2—type 1 diabetes mellitus	0.00017	0.00277	CbGpPWpGaD
Methyldopa—SLC15A1—Transmembrane transport of small molecules—CP—type 1 diabetes mellitus	0.00017	0.00276	CbGpPWpGaD
Methyldopa—ADRA2A—Regulation of insulin secretion—INS—type 1 diabetes mellitus	0.000168	0.00274	CbGpPWpGaD
Methyldopa—SLC15A1—Transmembrane transport of small molecules—SLC11A1—type 1 diabetes mellitus	0.000168	0.00274	CbGpPWpGaD
Methyldopa—COMT—Metabolism—G6PC2—type 1 diabetes mellitus	0.00016	0.0026	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—GAL—type 1 diabetes mellitus	0.00016	0.0026	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCL11—type 1 diabetes mellitus	0.000158	0.00257	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCL20—type 1 diabetes mellitus	0.000158	0.00257	CbGpPWpGaD
Methyldopa—DDC—Metabolism—ABCC8—type 1 diabetes mellitus	0.000156	0.00254	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CHRM2—type 1 diabetes mellitus	0.000149	0.00241	CbGpPWpGaD
Methyldopa—DDC—SIDS Susceptibility Pathways—TNF—type 1 diabetes mellitus	0.000147	0.00239	CbGpPWpGaD
Methyldopa—COMT—Metabolism—ABCC8—type 1 diabetes mellitus	0.000139	0.00226	CbGpPWpGaD
Methyldopa—ADRA2A—G alpha (i) signalling events—SST—type 1 diabetes mellitus	0.000138	0.00224	CbGpPWpGaD
Methyldopa—ADRA2A—Integration of energy metabolism—INS—type 1 diabetes mellitus	0.000132	0.00215	CbGpPWpGaD
Methyldopa—ADRA2A—GPCRs, Class A Rhodopsin-like—ADRB1—type 1 diabetes mellitus	0.000127	0.00207	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet activation, signaling and aggregation—PRKCQ—type 1 diabetes mellitus	0.000124	0.00202	CbGpPWpGaD
Methyldopa—DDC—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000124	0.00201	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—GAL—type 1 diabetes mellitus	0.000122	0.00198	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet activation, signaling and aggregation—VAV1—type 1 diabetes mellitus	0.000121	0.00196	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—CCL20—type 1 diabetes mellitus	0.00012	0.00195	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—CCL11—type 1 diabetes mellitus	0.00012	0.00195	CbGpPWpGaD
Methyldopa—SLC15A1—SLC-mediated transmembrane transport—ALB—type 1 diabetes mellitus	0.000119	0.00194	CbGpPWpGaD
Methyldopa—DDC—SIDS Susceptibility Pathways—IL6—type 1 diabetes mellitus	0.000119	0.00193	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—SELL—type 1 diabetes mellitus	0.000116	0.00188	CbGpPWpGaD
Methyldopa—ADRA2A—G alpha (i) signalling events—CXCL10—type 1 diabetes mellitus	0.000114	0.00186	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—CHRM2—type 1 diabetes mellitus	0.000113	0.00184	CbGpPWpGaD
Methyldopa—COMT—Metabolism—KCNJ11—type 1 diabetes mellitus	0.00011	0.00178	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—SST—type 1 diabetes mellitus	0.00011	0.00178	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet activation, signaling and aggregation—IGF2—type 1 diabetes mellitus	0.000109	0.00177	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—ADRB1—type 1 diabetes mellitus	0.000109	0.00177	CbGpPWpGaD
Methyldopa—DDC—Metabolism—ITPR3—type 1 diabetes mellitus	0.000104	0.0017	CbGpPWpGaD
Methyldopa—DDC—Metabolism—HBA1—type 1 diabetes mellitus	9.82e-05	0.0016	CbGpPWpGaD
Methyldopa—DDC—Metabolism—APOC3—type 1 diabetes mellitus	9.76e-05	0.00159	CbGpPWpGaD
Methyldopa—DDC—Circadian rythm related genes—IL6—type 1 diabetes mellitus	9.68e-05	0.00157	CbGpPWpGaD
Methyldopa—DDC—Metabolism—GSTT1—type 1 diabetes mellitus	9.59e-05	0.00156	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—IAPP—type 1 diabetes mellitus	9.5e-05	0.00154	CbGpPWpGaD
Methyldopa—COMT—Metabolism—ITPR3—type 1 diabetes mellitus	9.27e-05	0.00151	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet activation, signaling and aggregation—IL2RA—type 1 diabetes mellitus	9.19e-05	0.00149	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL10—type 1 diabetes mellitus	9.1e-05	0.00148	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—ITPR3—type 1 diabetes mellitus	9.08e-05	0.00148	CbGpPWpGaD
Methyldopa—ADRA2A—G alpha (i) signalling events—CCR5—type 1 diabetes mellitus	8.88e-05	0.00144	CbGpPWpGaD
Methyldopa—COMT—Metabolism—HBA1—type 1 diabetes mellitus	8.72e-05	0.00142	CbGpPWpGaD
Methyldopa—COMT—Metabolism—APOC3—type 1 diabetes mellitus	8.67e-05	0.00141	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—SH2B3—type 1 diabetes mellitus	8.55e-05	0.00139	CbGpPWpGaD
Methyldopa—COMT—Metabolism—GSTT1—type 1 diabetes mellitus	8.51e-05	0.00138	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—SST—type 1 diabetes mellitus	8.34e-05	0.00135	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—ADRB1—type 1 diabetes mellitus	8.3e-05	0.00135	CbGpPWpGaD
Methyldopa—ADRA2A—GPCRs, Class A Rhodopsin-like—CCR5—type 1 diabetes mellitus	8.24e-05	0.00134	CbGpPWpGaD
Methyldopa—DDC—Metabolism—GCG—type 1 diabetes mellitus	7.64e-05	0.00124	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—GCG—type 1 diabetes mellitus	7.43e-05	0.00121	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCR5—type 1 diabetes mellitus	7.06e-05	0.00115	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet activation, signaling and aggregation—IGF1—type 1 diabetes mellitus	7.01e-05	0.00114	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—CXCL10—type 1 diabetes mellitus	6.93e-05	0.00113	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—GAL—type 1 diabetes mellitus	6.88e-05	0.00112	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—NOS1—type 1 diabetes mellitus	6.83e-05	0.00111	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—CCL20—type 1 diabetes mellitus	6.8e-05	0.0011	CbGpPWpGaD
Methyldopa—COMT—Metabolism—GCG—type 1 diabetes mellitus	6.78e-05	0.0011	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—HBA2—type 1 diabetes mellitus	6.77e-05	0.0011	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet activation, signaling and aggregation—ALB—type 1 diabetes mellitus	6.64e-05	0.00108	CbGpPWpGaD
Methyldopa—DDC—Metabolism—CAT—type 1 diabetes mellitus	6.47e-05	0.00105	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—PRKCQ—type 1 diabetes mellitus	6.4e-05	0.00104	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—CHRM2—type 1 diabetes mellitus	6.39e-05	0.00104	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—G6PC2—type 1 diabetes mellitus	6.37e-05	0.00103	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—GAL—type 1 diabetes mellitus	6.25e-05	0.00101	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—VAV1—type 1 diabetes mellitus	6.21e-05	0.00101	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—CCL11—type 1 diabetes mellitus	6.18e-05	0.001	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—CCL20—type 1 diabetes mellitus	6.18e-05	0.001	CbGpPWpGaD
Methyldopa—SLC15A1—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	6.06e-05	0.000985	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—CHRM2—type 1 diabetes mellitus	5.81e-05	0.000943	CbGpPWpGaD
Methyldopa—COMT—Metabolism—CAT—type 1 diabetes mellitus	5.74e-05	0.000933	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—ITPR3—type 1 diabetes mellitus	5.74e-05	0.000932	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—IGF2—type 1 diabetes mellitus	5.63e-05	0.000914	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—ABCC8—type 1 diabetes mellitus	5.52e-05	0.000897	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet activation, signaling and aggregation—IL2—type 1 diabetes mellitus	5.39e-05	0.000875	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—CCR5—type 1 diabetes mellitus	5.37e-05	0.000873	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—IAPP—type 1 diabetes mellitus	5.37e-05	0.000872	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—ITPR3—type 1 diabetes mellitus	5.21e-05	0.000847	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—IAPP—type 1 diabetes mellitus	4.88e-05	0.000792	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—IL2RA—type 1 diabetes mellitus	4.74e-05	0.000769	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—SST—type 1 diabetes mellitus	4.71e-05	0.000766	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—ADRB1—type 1 diabetes mellitus	4.69e-05	0.000762	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—KCNJ11—type 1 diabetes mellitus	4.36e-05	0.000709	CbGpPWpGaD
Methyldopa—DDC—Metabolism—INS—type 1 diabetes mellitus	4.29e-05	0.000697	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—SST—type 1 diabetes mellitus	4.28e-05	0.000695	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—ADRB1—type 1 diabetes mellitus	4.26e-05	0.000692	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—GCG—type 1 diabetes mellitus	4.2e-05	0.000682	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—NOS2—type 1 diabetes mellitus	4.07e-05	0.000662	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	4.04e-05	0.000657	CbGpPWpGaD
Methyldopa—DDC—Metabolism—ALB—type 1 diabetes mellitus	3.93e-05	0.000639	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	3.93e-05	0.000638	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	3.92e-05	0.000636	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—GCG—type 1 diabetes mellitus	3.82e-05	0.00062	CbGpPWpGaD
Methyldopa—COMT—Metabolism—INS—type 1 diabetes mellitus	3.81e-05	0.000619	CbGpPWpGaD
Methyldopa—DDC—Metabolism—NOS3—type 1 diabetes mellitus	3.76e-05	0.000611	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—GAL—type 1 diabetes mellitus	3.69e-05	0.000599	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—ITPR3—type 1 diabetes mellitus	3.68e-05	0.000598	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	3.67e-05	0.000597	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—CCL20—type 1 diabetes mellitus	3.65e-05	0.000593	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—CCL11—type 1 diabetes mellitus	3.65e-05	0.000593	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—IGF1—type 1 diabetes mellitus	3.61e-05	0.000587	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—VAV1—type 1 diabetes mellitus	3.57e-05	0.000579	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	3.56e-05	0.000578	CbGpPWpGaD
Methyldopa—COMT—Metabolism—ALB—type 1 diabetes mellitus	3.49e-05	0.000568	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—HBA1—type 1 diabetes mellitus	3.47e-05	0.000563	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—APOC3—type 1 diabetes mellitus	3.44e-05	0.00056	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—CHRM2—type 1 diabetes mellitus	3.43e-05	0.000557	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—ALB—type 1 diabetes mellitus	3.42e-05	0.000556	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—GSTT1—type 1 diabetes mellitus	3.38e-05	0.00055	CbGpPWpGaD
Methyldopa—COMT—Metabolism—NOS3—type 1 diabetes mellitus	3.34e-05	0.000543	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—NOS3—type 1 diabetes mellitus	3.28e-05	0.000532	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—ITPR3—type 1 diabetes mellitus	3.08e-05	0.0005	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	3.04e-05	0.000493	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	2.99e-05	0.000486	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—SH2B3—type 1 diabetes mellitus	2.9e-05	0.000471	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—APOC3—type 1 diabetes mellitus	2.88e-05	0.000468	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—IAPP—type 1 diabetes mellitus	2.88e-05	0.000468	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—IL2—type 1 diabetes mellitus	2.78e-05	0.000451	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—CCR5—type 1 diabetes mellitus	2.76e-05	0.000448	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	2.72e-05	0.000442	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—GCG—type 1 diabetes mellitus	2.7e-05	0.000438	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—SST—type 1 diabetes mellitus	2.53e-05	0.000411	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—ADRB1—type 1 diabetes mellitus	2.52e-05	0.000409	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—CAT—type 1 diabetes mellitus	2.28e-05	0.000371	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—GCG—type 1 diabetes mellitus	2.25e-05	0.000366	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	2.17e-05	0.000352	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—VAV1—type 1 diabetes mellitus	2.11e-05	0.000342	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—CXCL10—type 1 diabetes mellitus	2.1e-05	0.000341	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—TYK2—type 1 diabetes mellitus	1.92e-05	0.000311	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—IGF2—type 1 diabetes mellitus	1.91e-05	0.00031	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—CD86—type 1 diabetes mellitus	1.84e-05	0.000298	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—IL2—type 1 diabetes mellitus	1.75e-05	0.000285	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—E2F1—type 1 diabetes mellitus	1.74e-05	0.000283	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—ERBB3—type 1 diabetes mellitus	1.66e-05	0.000269	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—CCR5—type 1 diabetes mellitus	1.63e-05	0.000265	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—IL2RA—type 1 diabetes mellitus	1.61e-05	0.000261	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—IL2—type 1 diabetes mellitus	1.59e-05	0.000259	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—INS—type 1 diabetes mellitus	1.51e-05	0.000246	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—ALB—type 1 diabetes mellitus	1.39e-05	0.000226	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—CD80—type 1 diabetes mellitus	1.34e-05	0.000218	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—NOS3—type 1 diabetes mellitus	1.33e-05	0.000216	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—INS—type 1 diabetes mellitus	1.27e-05	0.000206	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—IGF1—type 1 diabetes mellitus	1.22e-05	0.000199	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	1.22e-05	0.000198	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—TYK2—type 1 diabetes mellitus	1.13e-05	0.000184	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—NOS3—type 1 diabetes mellitus	1.11e-05	0.00018	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—CASP3—type 1 diabetes mellitus	9.43e-06	0.000153	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—IL2—type 1 diabetes mellitus	9.41e-06	0.000153	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—IL6—type 1 diabetes mellitus	9.37e-06	0.000152	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—STAT3—type 1 diabetes mellitus	7.92e-06	0.000129	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—EGFR—type 1 diabetes mellitus	7.2e-06	0.000117	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—IL6—type 1 diabetes mellitus	5.53e-06	8.99e-05	CbGpPWpGaD
